Merck KGaA (XTER:MRK)
€ 154.5 -1 (-0.64%) Market Cap: 67.17 Bil Enterprise Value: 75.03 Bil PE Ratio: 23.81 PB Ratio: 2.52 GF Score: 90/100

Merck KGaA at JPMorgan Healthcare Conference Transcript

Jan 13, 2020 / 05:00PM GMT
Release Date Price: €113.4 (-0.26%)
Richard Vosser
JP Morgan Chase & Co, Research Division - Senior Analyst

Are we ready? Yes? Okay. Welcome to the 38th JPMorgan European -- JPMorgan Healthcare Conference. I'm a European and my name is Richard Vosser. And it's my great pleasure to introduce Merck KGaA from Darmstadt at the conference and the CEO, Stefan Oschmann.

So before I hand over to Stefan, all I've got to say is that the breakout following this presentation is in the Olympic Room. Stefan, welcome to the conference.

Stefan Oschmann
MERCK Kommanditgesellschaft auf Aktien - Chairman of Executive Board & CEO

Thank you. Thank you, Richard. And good morning to all of you. For those of you who are new to us, just a couple of words of introduction. In terms of name, for legal reasons, I'm obliged to refer to us, when I'm in the U.S., to Merck KGaA, Darmstadt, Germany. Our -- what you know is MSD or Merck & Co. used to be our subsidiary, our U.S. subsidiary until 1917. And sort of historical events, the company split. We have friendly relationship with MSD, which doesn't

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot